The Peripheral Nerve Society Annual Meeting was held in Miami in May 2022. The Foundation for Peripheral Neuropathy is pleased to be able to provide a summary of some of the clinical studies presented at the conference. Study teams reported on natural history studies and (clinical) intervention trials for Peripheral Neuropathies who concluded over the …
The Foundation for Peripheral Neuropathy’s (FPN) Executive Director Lindsay Colbert was in attendance for a presentation by Melissa Elafros, MD, PhD, of the University of Michigan; Michelle Kvalsund, DO, MS, of the University of Zambia; and Brian Callahan MD, MS, of the University of Michigan at the Peripheral Nerve Society Annual Meeting in Miami. FPN …
The U.S. Department of Defense’s Peer Reviewed Medical Research Program (PRMRP) included peripheral neuropathy as a condition eligible for research funding for the first time ever in 2021. The Foundation for Peripheral Neuropathy (FPN) is proud to have been instrumental in making more funding available for PN research and researchers. For a second consecutive year, …
PRMRP Research Funding FY22: Now Accepting Applications Read More »
The Foundation for Peripheral Neuropathy is pleased to announce that peripheral neuropathy has been renewed as an eligible condition for Department of Defense (DOD) funds for the upcoming year. The Bill recently made it into law and FPN is proud that its lobbying campaign this past year was a success! Peer-Reviewed Medical Research Program The …
The Department of Defense’s (DoD) Peer-Reviewed Medical Research Program (PRMRP) has determined the grant applications that it wishes to award in fiscal year 2021 (FY21). In this first year that applications were accepted for research in peripheral neuropathy, 41 applications out of over 1000 applications received focused on peripheral neuropathy. DoD is recommending awarding a grant …
A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. …
AAN’s New Painful Diabetic Polyneuropathy Guidelines Read More »
Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels …
Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to …
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the …
FPN Welcomes the University of Michigan and Dr. Amro Stino Read More »
The Foundation for Peripheral Neuropathy (FPN) applauds action taken by Congress to designate “peripheral neuropathy” as a condition eligible for research funding from the Department of Defense’s (DoD) Peer Reviewed Medical Research Program (PRMRP). Language designating the condition eligible for funding is included in the fiscal year 2021 Omnibus Appropriations Act cleared yesterday by the …
FPN Applauds Congressional Action to Increase Research for Peripheral Neuropathy Read More »
